期刊文献+

知识产权国际保护标准的解读与启示——以利益平衡为视角 被引量:5

Interpretation and Implication of Standards of International Protection for Intellectual Property:From the Perspective of Blance of Benefits
下载PDF
导出
摘要 不断强化的全球知识产权保护体系制约了包括中国在内的发展中国家最优知识产权保护政策的制定。转换视角,运用法哲学与经济学的分析方法,正视发达国家过度追求经济利益与发展中国家追求发展之间的尖锐矛盾,正视现实中激励创造与保护公益间的失衡,理解与运用以《与贸易有关的知识产权协议》为核心的现行知识产权国际保护标准,恰当解释现有规则,制定我国最优知识产权实施政策,探究维护我国知识产权利益有效路径,是我们的明智选择。 The increasingly strengthened global system of ed the formulation of optimum IPR-protecting policies in protection for intellectual property has restraindeveloping countries with China included. If changing perspective to analyzing methods of legal philosophy and economics, we will face the reality of the intense contradiction between developed countries' excessive pursuit for economic benefits and developing countries' development as well as the imbalance between encouraging innovations and protecting public interests. It is also a wise choice for us to appropriately understand and apply the current standards of international protection for Intellectual Property with the core of TRIPS and appropriately explain the current rules in order to formulate the optimum intellectual property-protecting policies and to explore effective ways to protect interests of intellectual property in China.
机构地区 吉林大学法学院
出处 《吉林大学社会科学学报》 CSSCI 北大核心 2006年第4期75-82,共8页 Jilin University Journal Social Sciences Edition
基金 国家社会科学基金项目(03CFX012)
关键词 知识产权国际保护标准 利益均衡 利益失衡 standards of international protection for intellectual property balance of benefits imbalance of benefits
  • 相关文献

参考文献5

  • 1温家宝在山东考察时指出:世界未来竞争就是知识产权竞争[N].中国知识产权报,2004—06—26.
  • 2罗伯特·考特 托马斯·尤伦.法和经济学[M].上海:上海人民出版社,1994..
  • 3WIPO. The effects of TRIPS-jmandated intellectual property fights on economic activities in developing countries [J/OL].http://www.wipo.int, 2005 - 12 - 13.
  • 4Decision removes final patent obstacle to cheap drug imports [ J/OL]. http ://www. wto. org, 2003 -05 -30.
  • 5Clark A. D. Wilson. The TRIPS agreement: Is it beneficial to the developing world, or simply a tool used to protect pharmaceutical profits for developed world manufacturers? [ J ]. Journal of Technology Law & Policy, 2005, (12).

共引文献58

同被引文献23

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部